Restrictions On Marijuana Research

Despite the fact that many studies in the past have demonstrated the usefulness of marijuana, outdated regulations and attitudes have thwarted legitimate marijuana research. This is evident from the fact that even though marijuana’s usefulness can be gauged from the fact that it has been made legal in many states of the United States of America, there are many states that still term it as a Schedule 1 drug, alongside LSD and heroin.

The worst part is that marijuana has been defined as having no medical use and potentially additive in nature even though medical studies have proven that medical marijuana is one of the best drugs for treating health complications such as arthritis, neuropathic pain, nausea, spasticity, glaucoma, movement disorders, malignant tumors, HIV, the AIDS wasting syndrome, or dementia. Medical marijuana is also second to none when it comes to providing relief to patients suffering from health diseases, including hepatitis C, incontinence, multiple sclerosis, osteoporosis, chronic pain, Alzheimer’s disease, diabetes mellitus, fibromyalgia, Huntington’s disease, and Tourette’s syndrome.

If that was not all, the marijuana provided by he National Institute on Drug Abuse (NIDA) is regarded as less potent when compared to the marijuana often easily available on the street. Furthermore, studies that emphasize on finding the positive benefits of marijuana smoking are not easily funded, while those highlighting negative effects of marijuana get easy funds.